Moupali Das

Moupali Das

UNVERIFIED PROFILE

Are you Moupali Das?   Register this Author

Register author
Moupali Das

Moupali Das

Publications by authors named "Moupali Das"

Are you Moupali Das?   Register this Author

43Publications

854Reads

24Profile Views

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.

J Acquir Immune Defic Syndr 2017 06;75(2):211-218

*Infectious Diseases Unit, Internal Medicine Service, Hospital Universitario La Paz, Madrid, ES; †AIDS Research Consortium of Atlanta, Atlanta, GA; ‡Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; §Internal Medicine, General Hospital Graz-West, Graz, AT; ‖Tarrant County Infectious Disease Associates, Fort Worth, TX; ¶Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC; #Orlando Immunology Center, Orlando, FL; **Claude Nicol Centre, Royal Sussex County Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom; and ††Departments of Biometrics, Virology, Clinical Operations, and HIV Clinical Research, Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001350DOI Listing
June 2017

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

J Acquir Immune Defic Syndr 2017 Feb;74(2):180-184

*Department of Sexual Health, King's College Hospital NHS Foundation Trust, London, United Kingdom; †Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ‡Department of Sexual Health, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom; §Department of Infectious Diseases, Croix-Rousse Hospital, Hospices Civils de Lyon, France; and ‖Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228610PMC
February 2017

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults.

J Acquir Immune Defic Syndr 2017 Feb;74(2):193-200

*The Ruth M. Rothstein CORE Center, Chicago, IL; †Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ‡Southwest CARE Center, Santa Fe, NM; §Division of Infectious Diseases, Weill Cornell Medicine, New York, NY; and ‖Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228611PMC
February 2017

Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.

J Acquir Immune Defic Syndr 2016 11;73(3):294-298

*Southwest CARE Center, Santa Fe, NM; †Family and Community Medicine, University of Toronto, Ontario, Canada; ‡Crofoot Research Center, Houston, TX; §Be Well Medical Center, Berkley, MI; ‖Southern California Men's Medical Group, Los Angeles, CA; ¶Central Texas Clinical Research, Austin, TX; #AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; and **Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172523PMC
November 2016

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.

J Acquir Immune Defic Syndr 2016 May;72(1):58-64

*Department of Medicine, University of North Carolina, Chapel Hill, NC; †AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; ‡Department of Infectious Diseases, CHU Saint-Pierre University Hospital Brussels, Brussels, Belgium; §Elton John centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom; ‖Central Texas Clinical Research, Austin, TX; ¶Department of Internal Medicine, Mercer University School of Medicine, Macon, GA; #The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI; **Infectious Diseases Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ††Capital Center for Travel and Tropical Medicine, Washington, DC; ‡‡Internal Medicine Unit, Le Kremlin-Bicêtre Hospital, AP-HP Infectious Diseases Unit, Centre Hospitalier de Tourcoing Descartes University, Necker Hospital, AP-HP, Paris, France; §§Medicine, Maple Leaf Research, Department of Family and Community Medicine, University of Toronto, Toronto, CA; ‖‖Clinica delle Malattie Infettive e Tropicali, University of Modena and Reggio Emilia, Modena, Italy; ¶¶Department of Medicine and Center for AIDS Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ##Division of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; and ***Gilead Sciences, Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000940DOI Listing
May 2016

Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients.

AIDS Behav 2016 Jan;20(1):204-14

Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, 722 W. 168th St, Rm 934, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10461-015-1074-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637257PMC
January 2016

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.

J Acquir Immune Defic Syndr 2015 Aug;69(4):439-45

*Gordon Crofoot Research, Southern California Men's Medical Group/Men's Health Foundation, Assistant Professor of Clinical Medicine, Univeristy of California, Los Angeles, Los Angeles, CA; †Houston, TX; ‡Tarrant County Infectious Disease Associates, Fort Worth, TX; §Clinical Associate Professor in the Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA; ‖Kaiser Permanente, Sacramento, CA; ¶Therapeutic Concepts, Houston, TX; #DCOL Center for Clinical Research, Longview, TX; **La Playa Medical Group and Clinical Research, San Diego, CA; ††Center for AIDS Research, The University of Alabama at Birmingham, Birmingham, AL; and ‡‡Gilead Sciences, Foster City, CA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jaids/2015/08010/Tenofovir_Alaf
Web Search
http://www.thelancet.com/pdfs/journals/lanhiv/PIIS2352-3018(
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000000618DOI Listing
August 2015

Using Twitter to survey alcohol use in the San Francisco Bay Area.

Epidemiology 2015 Jul;26(4):e39-40

University of California, San Francisco, CA University of California, Berkeley, CA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000315DOI Listing
July 2015

Beyond measuring what matters to managing what matters: improving public health quality and accountability in the U.S. HIV epidemic response.

Authors:
Moupali Das

Public Health Rep 2013 Sep-Oct;128(5):360-3

San Francisco Department of Public Health, San Francisco, CA ; University of California, San Francisco, San Francisco General, Division of HIV/AIDS and Infectious Diseases, San Francisco, CA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743283PMC
http://dx.doi.org/10.1177/003335491312800505DOI Listing
November 2013

Linkage to HIV care in San Francisco: implications of measure selection.

J Acquir Immune Defic Syndr 2013 Nov;64 Suppl 1:S27-32

*San Francisco Department of Public Health, San Francisco, CA; and †Divisions of HIV/AIDS and Infectious Diseases, San Francisco General Hospital, University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a99c73DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078743PMC
November 2013

Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Addiction 2013 Apr 3;108(4):751-61. Epub 2013 Jan 3.

San Francisco Department of Public Health, San Francisco, California, USA; University of California, San Francisco, CA 94102, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/add.12073
Publisher Site
http://dx.doi.org/10.1111/add.12073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602333PMC
April 2013

Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness.

Addict Behav 2012 Apr 14;37(4):552-5. Epub 2011 Dec 14.

Department of Medicine and Department of Public Health and Preventive Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addbeh.2011.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288438PMC
April 2012

Interventions for non-injection substance use among US men who have sex with men: what is needed.

AIDS Behav 2011 Apr;15 Suppl 1:S51-6

San Francisco Department of Public Health, HIV Prevention Section, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10461-011-9923-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064889PMC
April 2011

Linkage and retention in HIV care among men who have sex with men in the United States.

Clin Infect Dis 2011 Jan;52 Suppl 2:S214-22

San Francisco General Hospital, University of California San Francisco, San Francisco, California 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciq045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106256PMC
January 2011